Rekonvaleszentenplasma/ convalescent plasma
Letzte Änderung:
Fresh (max. 6 months old) high- titer reconvasencent plasma of previously vaccinates donors can help immunocompromised patients clear the virus. The earlier it is given - the better.
Vor einer Gabe an erkrankte Patienten sollte ausgeschlossen werden, dass der Plasmaspender Antikörper gegen Interferon hatte.
Quellen (115)
Markiert sind besonders wichtige Quellen.
-
Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources
nature.com, hinzugefügt am 06.03.2023, wichtige Quelle
-
COVID-19 Convalescent Plasma for the Treatment of Immunocompromised Patients: A Systematic Review and Meta-analysis
jamanetwork.com, hinzugefügt am 06.03.2023, wichtige Quelle
-
COVID-19: Rekonvaleszentenplasma mit hohem Antikörpertiter halbiert Hospitalisierungsrate
aerzteblatt.de, hinzugefügt am 23.12.2021, wichtige Quelle
-
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
jamanetwork.com, hinzugefügt am 20.06.2021, wichtige Quelle
-
Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
ashpublications.org, hinzugefügt am 06.04.2021, wichtige Quelle
-
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
nejm.org, hinzugefügt am 07.01.2021, wichtige Quelle
-
Vaccine-boosted convalescent plasma therapy for patients with immunosuppression and COVID-19
ashpublications.org, hinzugefügt am 05.08.2023
-
COVID-19 convalescent plasma utilization in the United States: data from the National Inpatient Sample
academic.oup.com, hinzugefügt am 10.04.2023
-
Convalescent Plasma Therapy for COVID-19: A Systematic Review and Meta-Analysis on Randomized Controlled Trials
mdpi.com, hinzugefügt am 07.04.2023
-
Convalescent Plasma Treatment of Patients Previously Treated with B-Cell-Depleting Monoclonal Antibodies Suffering COVID-19 Is Associated with Reduced Re-Admission Rates
mdpi.com, hinzugefügt am 07.04.2023
-
COVID-19 Convalescent Plasma Outpatient Therapy to Prevent Outpatient Hospitalization: A Meta-analysis of Individual Participant Data From Five Randomized Trials
academic.oup.com, hinzugefügt am 06.03.2023
-
Twiv 987
microbe.tv, hinzugefügt am 06.03.2023
-
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
nejm.org, hinzugefügt am 06.03.2023
-
Plasma from vaccinated and COVID-19 convalescent subjects as passive immunotherapy against the new Omicron BQ.1.1, XBB, and BF.7 variants
news-medical.net, hinzugefügt am 06.12.2022
-
Plasma after both SARS-CoV-2 boosted vaccination and COVID-19 potently neutralizes BQ.1.1 and XBB.1
biorxiv.org, hinzugefügt am 06.12.2022
-
Recombinant human plasma gelsolin reverses increased permeability of the blood–brain barrier induced by the spike protein of the SARS-CoV-2 virus
jneuroinflammation.biomedcentral.com, hinzugefügt am 29.11.2022
-
Limitations on PassItOn Design and Execution Should Temper Negative Conclusions
sciencedirect.com, hinzugefügt am 05.11.2022
-
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
jamanetwork.com, hinzugefügt am 26.10.2022
-
Nucleocapsid-specific antibody function is associated with therapeutic benefit from Covid-19 Convalescent plasma therapy
cell.com, hinzugefügt am 26.10.2022
-
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
nejm.org, hinzugefügt am 03.04.2022
-
Once Viewed as a Promising COVID-19 Treatment, Convalescent Plasma Falls Out of Favor
jamanetwork.com, hinzugefügt am 11.03.2022
-
High Viral Specific Antibody Convalescent Plasma Effectively Neutralizes SARS-CoV-2 Variants of Concern
medrxiv.org, hinzugefügt am 06.03.2022
-
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma
jamanetwork.com, hinzugefügt am 17.02.2022
-
High-Dose Convalescent Plasma for Treatment of Severe COVID-19
wwwnc.cdc.gov, hinzugefügt am 17.02.2022
-
Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19
jamanetwork.com, hinzugefügt am 17.02.2022
-
Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma
jamanetwork.com, hinzugefügt am 17.02.2022
-
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma
medrxiv.org, hinzugefügt am 14.02.2022
-
Pharmacokinetics of high-titer anti–SARS-CoV-2 human convalescent plasma in high-risk children
insight.jci.org, hinzugefügt am 14.02.2022
-
Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron
nature.com, hinzugefügt am 10.01.2022
-
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma
medrxiv.org, hinzugefügt am 26.12.2021
-
Activity of convalescent and vaccine serum against a B.1.1.529 variant SARS-CoV-2 isolate
medrxiv.org, hinzugefügt am 25.12.2021
-
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients
jamanetwork.com, hinzugefügt am 21.12.2021
-
Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients
jamanetwork.com, hinzugefügt am 18.12.2021
-
SARS-CoV-2 Omicron Spike Glycoprotein Receptor Binding Domain Exhibits Super-Binder Ability with ACE2 but not Convalescent Monoclonal Antibody
biorxiv.org, hinzugefügt am 13.12.2021
-
COVID-19: WHO rät von Behandlung mit Rekonvaleszentenserum ab
aerzteblatt.de, hinzugefügt am 07.12.2021
-
SARS-CoV-2: Serumtherapie kommt bei Intensivpatienten zu spät
aerzteblatt.de, hinzugefügt am 06.10.2021
-
Effect of Convalescent Plasma on Organ Support–Free Days in Critically Ill Patients With COVID-19
jamanetwork.com, hinzugefügt am 05.10.2021
-
A highly potent antibody effective against SARS-CoV-2 variants of concern
cell.com, hinzugefügt am 29.09.2021
-
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial
nature.com, hinzugefügt am 14.09.2021
-
Early Convalescent Plasma for High-Risk Outpatients with Covid-19
nejm.org, hinzugefügt am 24.08.2021
-
SARS-CoV-2: Serumtherapie scheitert in weiterer Studie
aerzteblatt.de, hinzugefügt am 24.08.2021
-
SARS-CoV-2 escape from a highly neutralizing COVID-19 convalescent plasma
pnas.org, hinzugefügt am 24.08.2021
-
Überantibodies From Recovered COVID-19 Patients Could Spur New Therapeutics and Vaccines
jamanetwork.com, hinzugefügt am 06.08.2021
-
Plasma from patients with bacterial sepsis or severe COVID-19 induces suppressive myeloid cell production from hematopoietic progenitors in vitro
stm.sciencemag.org, hinzugefügt am 09.07.2021
-
Behandlung von COVID-19 mit Rekonvaleszentenplasma: Uneinheitliche Studienlage erschwert die Bewertung
aerzteblatt.de, hinzugefügt am 09.07.2021
-
COVID-19: Serumtherapie kann bei hämatologischen Krebspatienten erfolgreich sein
aerzteblatt.de, hinzugefügt am 21.06.2021
-
Convalescent plasma therapy in patients with moderate-to-severe COVID-19: A study from Indonesia for clinical research in low- and middle-income countries
thelancet.com, hinzugefügt am 20.06.2021
-
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
thelancet.com, hinzugefügt am 22.05.2021
-
A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19
jci.org, hinzugefügt am 20.05.2021
-
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
sciencedirect.com, hinzugefügt am 16.05.2021
-
SARS-CoV-2 cell-to-cell infection is resistant to neutralizing antibodies
biorxiv.org, hinzugefügt am 07.05.2021
-
Podcast zu Plasma
microbe.tv, hinzugefügt am 05.04.2021
-
Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19
thelancet.com, hinzugefügt am 03.04.2021
-
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
nature.com, hinzugefügt am 29.03.2021
-
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
nature.com, hinzugefügt am 18.03.2021
-
High levels of common cold coronavirus antibodies in convalescent plasma are associated with improved survival in COVID-19 patients
medrxiv.org, hinzugefügt am 11.03.2021
-
Convalescent Plasma Strikes Out As COVID-19 Treatment
npr.org, hinzugefügt am 10.03.2021
-
Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies
nature.com, hinzugefügt am 07.03.2021
-
NIH halts trial of COVID-19 convalescent plasma in emergency department patients with mild symptoms
nih.gov, hinzugefügt am 03.03.2021
-
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19
jamanetwork.com, hinzugefügt am 27.02.2021
-
Study finds short window for donating convalescent plasma to COVID-19 patients
news.psu.edu, hinzugefügt am 26.02.2021
-
Use of convalescent serum reduces severity of COVID-19 in nonhuman primates
cell.com, hinzugefügt am 24.02.2021
-
BIOTEST AUS DREIEICH: Blutplasma gegen Covid-19
faz.net, hinzugefügt am 19.02.2021
-
Clinical and laboratory evaluation of patients with SARS-CoV-2 pneumonia treated with high-titer convalescent plasma
pubmed.ncbi.nlm.nih.gov, hinzugefügt am 14.02.2021
-
Multi-clonal SARS-CoV-2 neutralization by antibodies isolated from severe COVID-19 convalescent donors
journals.plos.org, hinzugefügt am 12.02.2021
-
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
nejm.org, hinzugefügt am 10.02.2021
-
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies
secure.jbs.elsevierhealth.com, hinzugefügt am 10.02.2021
-
SARS-CoV-2: FDA schränkt Verwendung von Serumtherapie ein
aerzteblatt.de, hinzugefügt am 10.02.2021
-
Convalescent Plasma and Improved Survival in Patients with Hematologic Malignancies and COVID-19
medrxiv.org, hinzugefügt am 06.02.2021
-
SARS-CoV-2 neutralizing antibodies; longevity, breadth, and evasion by emerging viral variants
medrxiv.org, hinzugefügt am 30.01.2021
-
Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein
biorxiv.org, hinzugefügt am 29.01.2021
-
Enhancement versus neutralization by SARS-CoV-2 antibodies from a convalescent donor associates with distinct epitopes on the RBD
pubmed.ncbi.nlm.nih.gov, hinzugefügt am 28.01.2021
-
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
cell.com, hinzugefügt am 28.01.2021
-
Escape of SARS-CoV-2 501Y.V2 variants from neutralization by convalescent plasma
medrxiv.org, hinzugefügt am 27.01.2021
-
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19
science.sciencemag.org, hinzugefügt am 27.01.2021
-
Vaccination Against the New Variants: Real-World Data
blogs.sciencemag.org, hinzugefügt am 27.01.2021
-
Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization
biorxiv.org, hinzugefügt am 27.01.2021
-
Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies
biorxiv.org, hinzugefügt am 24.01.2021
-
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
biorxiv.org, hinzugefügt am 20.01.2021
-
SARS-CoV-2: Serumtherapie enttäuscht in der RECOVERY-Studie
aerzteblatt.de, hinzugefügt am 19.01.2021
-
RECOVERY trial closes recruitment to convalescent plasma treatment for patients hospitalised with COVID-19
recoverytrial.net, hinzugefügt am 16.01.2021
-
Early High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults
nejm.org, hinzugefügt am 14.01.2021
-
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
nejm.org, hinzugefügt am 14.01.2021
-
Enhancement versus Neutralization by SARS-CoV-2 Antibodies from A Convalescent Donor Associates with Distinct Epitopes on the Receptor-Binding Domain
cell.com, hinzugefügt am 13.01.2021
-
Update on recruitment to convalescent plasma and tocilizumab treatment arms
recoverytrial.net, hinzugefügt am 12.01.2021
-
Neutralising antibodies in Spike mediated SARS-CoV-2 adaptation
medrxiv.org, hinzugefügt am 11.01.2021
-
Trial of COVID-19 blood plasma finds no benefit in severely ill patients
reuters.com, hinzugefügt am 11.01.2021
-
COVID-19: Hochdosierte Serumtherapie in Frühphase der Erkrankung effektiv
aerzteblatt.de, hinzugefügt am 09.01.2021
-
COVID research updates: Quick treatment with antibody-laden blood cuts risk of severe COVID
nature.com, hinzugefügt am 08.01.2021
-
Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors
medrxiv.org, hinzugefügt am 08.01.2021
-
SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma
biorxiv.org, hinzugefügt am 31.12.2020
-
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes in COVID-19 convalescent plasma
biorxiv.org, hinzugefügt am 23.12.2020
-
Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
medrxiv.org, hinzugefügt am 20.12.2020
-
The Assessment of Convalescent Plasma Efficacy against COVID-19
cell.com, hinzugefügt am 19.12.2020
-
Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies
pubmed.ncbi.nlm.nih.gov, hinzugefügt am 15.12.2020
-
Convalescent Plasma-Mediated Resolution of COVID-19 in a Patient with Humoral Immunodeficiency
cell.com, hinzugefügt am 08.12.2020
-
Treatment of Severe COVID-19 with Convalescent Plasma in the Bronx, NYC
medrxiv.org, hinzugefügt am 07.12.2020
-
Clinical and immunological benefits of convalescent plasma therapy in severe COVID-19: insights from a single center open label randomised control trial
medrxiv.org, hinzugefügt am 30.11.2020
-
SARS-CoV-2: Serumtherapie bleibt in randomisierter Studie ohne Wirkung
aerzteblatt.de, hinzugefügt am 27.11.2020
-
Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia
nejm.org, hinzugefügt am 25.11.2020
-
Convalescent plasma therapy for B-cell–depleted patients with protracted COVID-19
ashpublications.org, hinzugefügt am 23.11.2020
-
Prevention of severe COVID-19 in the elderly by early high-titer plasma
medrxiv.org, hinzugefügt am 22.11.2020
-
longitudinal study with proposals for better quality of CCP collections.
medrxiv.org, hinzugefügt am 17.11.2020
-
Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19
stm.sciencemag.org, hinzugefügt am 13.11.2020
-
Therapeutic use of convalescent plasma in COVID-19 patients with immunodeficiency: A systematic review
medrxiv.org, hinzugefügt am 11.11.2020
-
T-cells Are Rapidly Expanded for Therapeutic Use
ashpublications.org, hinzugefügt am 05.11.2020
-
Antibodies in serum of convalescent patients following mild COVID‐19 do not always prevent virus‐receptor binding
onlinelibrary.wiley.com, hinzugefügt am 04.11.2020
-
Convalescent Plasma Reveals a Signal of Significantly Decreased Mortality
ajp.amjpathol.org, hinzugefügt am 04.11.2020
-
senkt Sterblichkeit nur in der Frühphase der Erkrankung
aerzteblatt.de, hinzugefügt am 04.11.2020
-
Antiphospholipid-Antikörper könnten thrombotische Komplikationen (und Versagen einer Serumtherapie) erklären
aerzteblatt.de, hinzugefügt am 03.11.2020
-
keine Wirksamkeit
bmj.com, hinzugefügt am 01.11.2020
-
Plasma
biorxiv.org, hinzugefügt am 01.11.2020
-
Convalescent plasma treatment - Studie
nature.com, hinzugefügt am 01.11.2020
-
Rekonvaleszentenplasma
bmj.com, hinzugefügt am 01.11.2020
-
bei B-Zell Mangel
ashpublications.org, hinzugefügt am 01.11.2020